Y-Intercept (HK)’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-847
| Closed | -$206K | – | 1639 |
|
|
2025
Q1 | $206K | Buy |
+847
| New | +$206K | 0.01% | 1046 |
|
|
2024
Q4 | – | Sell |
-6,679
| Closed | -$2.23M | – | 1200 |
|
|
2024
Q3 | $2.23M | Buy |
+6,679
| New | +$2.23M | 0.14% | 183 |
|
|
2023
Q4 | – | Sell |
-3,150
| Closed | -$1.13M | – | 1237 |
|
|
2023
Q3 | $1.13M | Buy |
+3,150
| New | +$1.13M | 0.11% | 275 |
|
|
2023
Q2 | – | Sell |
-1,047
| Closed | -$502K | – | 1279 |
|
|
2023
Q1 | $502K | Buy |
+1,047
| New | +$502K | 0.06% | 528 |
|
|
2022
Q4 | – | Sell |
-3,793
| Closed | -$1.58M | – | 1008 |
|
|
2022
Q3 | $1.58M | Buy |
+3,793
| New | +$1.58M | 0.16% | 192 |
|
|
2022
Q2 | – | Sell |
-1,871
| Closed | -$1.05M | – | 870 |
|
|
2022
Q1 | $1.05M | Buy |
+1,871
| New | +$1.05M | 0.24% | 103 |
|
|
2021
Q4 | – | Sell |
-2,219
| Closed | -$1.66M | – | 588 |
|
|
2021
Q3 | $1.66M | Buy |
+2,219
| New | +$1.66M | 0.3% | 92 |
|
|
2021
Q2 | – | Sell |
-585
| Closed | -$330K | – | 629 |
|
|
2021
Q1 | $330K | Buy |
+585
| New | +$330K | 0.09% | 369 |
|